FDA 483 - Sucampo Pharma, LLC
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Sucampo Pharmaceuticals, LLC, an API manufacturer in Sanda, Japan, was cited for four observations during an FDA inspection. The inspection revealed issues including incomplete investigations into manufacturing deviations, unvalidated process parameters for drug substance dissolution, and inadequate investigation of product complaints. Additionally, the firm's gas chromatography instrument and software had a shared login and allowed data overwriting, raising data integrity concerns.
- Company
- Sucampo Pharma, LLC
- Product Type
- Drugs
- Person
ID · 822f9511-00e3-4c6c-8564-a66d8b7bfa69